This is the web version of the Bull Sheet, Fortune’s no-BS daily newsletter on the markets. Sign up to receive it in your inbox here.
Good morning. It’s a Monday, which means a fresh batch of COVID vaccine news jolting the markets. This time it comes from team Britain—AstraZeneca and Oxford University. Their latest trials show impressive results, or so the markets believe. Stocks in Asia and Europe are up, and U.S. futures are in the green.
The vaccine can’t come soon enough. The U.S. COVID numbers are frightening (but that’s hardly stopping travelers from getting onto planes to see grandma).
Let’s check in on the action.
- The major Asia indexes are mixed in afternoon trading with Japan’s Nikkei down 0.4% and the Shanghai Composite up 1.1%.
- The Trump Administration has drawn up a list of 89 companies, mostly in aerospace, that would